The dexamethasone nanowafer: A novel method of drug delivery for dry eye disease
September 1st 2015This review presents a therapeutic nanowafer as an alternative to eye drops for dry eye disease, designed to enhance efficacy and improve patient compliance to treatment. In an experimental animal study, the novel dexamethasone nanowafer drug delivery system was comparable in efficacy to twice-daily dexamethasone eye drop treatment and has the potential to minimise risk of cataract formation and glaucoma.
Managing progressive keratoconus with the triple procedure
September 1st 2015Findings from a study undertaken at Dr Lovisolo’s practice indicate that in carefully-selected patients, a triple procedure, comprising Keraring implantation followed by accelerated CXL and topo-guided ablation can provide significant functional improvement in cases of progressive keratoconus.
Anterior capsulotomy is the main prostaglandin release inducer in FLACS
September 1st 2015Research presented in this article found anterior capsulotomy to be the main trigger for an increase of prostaglandins in aqueous humor immediately after laser-assisted cataract surgery. Optimised energy settings in combination with NSAIDs might therefore help reduce laser-induced miosis.
Pseudoexfoliation may play greater role in late IOL subluxation/dislocation
September 1st 2015Histopathologic analysis of 53 consecutive IOL-capsular bag specimens explanted after late in-the-bag IOL subluxation/dislocation identified pseudoexfoliation in 33(62%) of cases-less than half of which had a clinical diagnosis of pseudoexfoliation.
Clinical Round Up: No glaucoma protection from primary IOL placement in children
August 27th 2015In this month's Clinical Round Up, Sharon Freedman, MD, discusses results of the Infant Aphasia Treatment Study, and how it found there is no glaucoma protection from primary IOL placement in children. Additionally, Barbara Parolini, MD, discusses the new hope for better myopic traction maculopathy outcomes.
Tips for handling the business side of medicine
August 1st 2015n this installment of Sight Lines, J.C. Noreika, MD, MBA, talks with Michael L. Stark, JD, who has represented physicians for more than 50 years as his primary client base. Among the topics they discuss is the watershed moment that enabled physicians to incorporate and take advantage of business-tax deduction provisions.